IP Tokens of IPNFT #129 current market price is $0.603 with a 24 hour trading volume of $13,152. The total available supply of IP Tokens of IPNFT #129 is 1,100.00K CLAW with a maximum supply of (Not Available) CLAW. It has secured Rank 4644 in the cryptocurrency market with a marketcap of $663.74K. The CLAW price is -5.8% down in the last 24 hours.
The lowest price of the IP Tokens of IPNFT #129 is $0.601 & the highest price is $0.666 in the last 24 hours. Live IP Tokens of IPNFT #129 prices from all markets and CLAW coin market Capitalization. Stay up to date with the latest IP Tokens of IPNFT #129 price movements. Check our coin stats data and see when there is an opportunity to buy or sell IP Tokens of IPNFT #129 at best price in the market.
#4644
$0.603
$-0.04 -5.8%
$0.601 / $0.666
$663.74K -5.75%
$13,152
1,100.00K CLAW
(Not Available) CLAW
Want to convert more cryptocurrencies?
-5.8%
-12.45%
58.73%
0%
0%
0%
Compare live prices of IP Tokens of IPNFT #129 on top exchanges.
| # | Exchange | Pair | Price | Volume (24h) |
|---|---|---|---|---|
| Aerodrome (Base) | 0X93757.../0X42000... | $0.604 | $6,738 | |
| Aerodrome (Base) | 0X226A2.../0X93757... | $0.604 | $6,432 |
Percepta® is a patent-protected brain health natural dietary supplement (active ingredients, PTI-00703® Cat’s claw and MemorTea® - a specific oolong tea extract). Cerebrum DAO will be supporting the development of near- and long-term solutions for targeting cognitive decline, memory loss and neurodegenerative diseases. The global market for brain health supplements is over $8.6b - most if not all lack clinical evidence to support efficacy. Percepta® has robust patent protection and highly promising research results. Percepta has the potential to be the category leader in this fast growing $8.6b market with human evidence to support outcomes and the funding of future studies that could lead to FDA botanical drug status which is the ultimate goal. This IP-NFT represents a world’s first tokenization of a robust patent portfolio and a world’s first tokenized crowdsale for a clinical evidence study. Success with this study can lead to future trials that create the potential for FDA botanical drug approval, potentially unlocking broad access to improve brain health globally.
https://www.cerebrumdao.com/projects/percepta-brain
https://basescan.org/token/0x93757336de76f24f7eee15e6150e4ec42fbdaa21
